questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Utilisations thérapeutiques
Agents hématologiques
Anticoagulants
Antithrombiniques
Antithrombiniques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Thrombose
Échographie
D-dimères
Anticoagulants
Temps de prothrombine
INR
Embolie
Douleur thoracique
Essoufflement
Insuffisance veineuse
Doppler
Examen physique
Thrombose veineuse
Œdème
Douleur
Symptômes
5
Thrombose
Douleur
Gonflement
Embolie pulmonaire
Tachycardie
Essoufflement
Hémorragie
Saignement
Ecchymoses
Thrombopénie
Saignements
Pétéchies
Thromboembolie
Cyanose
Douleur
Prévention
5
Thrombose
Prévention
Exercice
Anticoagulants
Risque
Voyages
Bas de compression
Circulation
Thrombose
Alimentation
Vitamine K
Anticoagulants
Facteurs de risque
Poids
Tabac
Traitements
5
Antithrombiniques
Héparine
Warfarine
Héparine
Injection
Anticoagulants
Anticoagulants
Effets secondaires
Saignements
Anticoagulants
INR
Temps de prothrombine
Thrombose veineuse
Anticoagulants
Compression
Complications
5
Anticoagulants
Hémorragies
Thrombopénie
Surdose
Anticoagulants
Saignements
Hémorragie
Anticoagulants
Consultation médicale
Thrombose
Embolie pulmonaire
Syndrome post-thrombotique
Anticoagulants
Saignements
Coagulation
Facteurs de risque
5
Thrombose
Obésité
Antécédents familiaux
Âge
Thrombose
Circulation sanguine
Tabagisme
Thrombose
Inflammation
Maladies chroniques
Diabète
Hypertension
Grossesse
Thrombose
Changements hormonaux
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Antithrombiniques : Questions médicales les plus fréquentes",
"headline": "Antithrombiniques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Antithrombiniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-27",
"dateModified": "2025-04-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Antithrombiniques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Anticoagulants",
"url": "https://questionsmedicales.fr/mesh/D000925",
"about": {
"@type": "MedicalCondition",
"name": "Anticoagulants",
"code": {
"@type": "MedicalCode",
"code": "D000925",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.119"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs du facteur Xa",
"alternateName": "Factor Xa Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D065427",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs du facteur Xa",
"code": {
"@type": "MedicalCode",
"code": "D065427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.954.502.119.500.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Antithrombiniques",
"alternateName": "Antithrombins",
"code": {
"@type": "MedicalCode",
"code": "D000991",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Vicente Vicente",
"url": "https://questionsmedicales.fr/author/Vicente%20Vicente",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain."
}
},
{
"@type": "Person",
"name": "Javier Corral",
"url": "https://questionsmedicales.fr/author/Javier%20Corral",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain."
}
},
{
"@type": "Person",
"name": "Irene Martínez-Martínez",
"url": "https://questionsmedicales.fr/author/Irene%20Mart%C3%ADnez-Mart%C3%ADnez",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain. Electronic address: immlgi@um.es."
}
},
{
"@type": "Person",
"name": "Belén de la Morena-Barrio",
"url": "https://questionsmedicales.fr/author/Bel%C3%A9n%20de%20la%20Morena-Barrio",
"affiliation": {
"@type": "Organization",
"name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain."
}
},
{
"@type": "Person",
"name": "Zsuzsanna Bereczky",
"url": "https://questionsmedicales.fr/author/Zsuzsanna%20Bereczky",
"affiliation": {
"@type": "Organization",
"name": "Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Interactive Learning System for Learning Calculus.",
"datePublished": "2024-03-11",
"url": "https://questionsmedicales.fr/article/38765243",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12688/f1000research.73595.2"
}
},
{
"@type": "ScholarlyArticle",
"name": "An empirical study on learners' learning emotion and learning effect in offline learning environment.",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37972001",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0294407"
}
},
{
"@type": "ScholarlyArticle",
"name": "The hard problem of meta-learning is what-to-learn.",
"datePublished": "2024-09-23",
"url": "https://questionsmedicales.fr/article/39311527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/S0140525X24000268"
}
},
{
"@type": "ScholarlyArticle",
"name": "Describing movement learning using metric learning.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36735670",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0272509"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lifelong learning in community healthcare: Testing competence after learning activities in a blended learning space.",
"datePublished": "2023-05-18",
"url": "https://questionsmedicales.fr/article/37203208",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/scs.13180"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Utilisations thérapeutiques",
"item": "https://questionsmedicales.fr/mesh/D045506"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agents hématologiques",
"item": "https://questionsmedicales.fr/mesh/D006401"
},
{
"@type": "ListItem",
"position": 6,
"name": "Anticoagulants",
"item": "https://questionsmedicales.fr/mesh/D000925"
},
{
"@type": "ListItem",
"position": 7,
"name": "Antithrombiniques",
"item": "https://questionsmedicales.fr/mesh/D000991"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Antithrombiniques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Antithrombiniques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Antithrombiniques",
"description": "Comment diagnostiquer une thrombose ?\nQuels tests pour évaluer l'anticoagulation ?\nQuels symptômes indiquent une embolie ?\nComment détecter une insuffisance veineuse ?\nQuels signes cliniques d'une thrombose veineuse ?",
"url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Learning#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Antithrombiniques",
"description": "Quels sont les symptômes d'une thrombose ?\nComment reconnaître une embolie pulmonaire ?\nQuels symptômes d'une hémorragie ?\nQuels signes d'une thrombopénie ?\nComment se manifeste une crise thromboembolique ?",
"url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Learning#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Antithrombiniques",
"description": "Comment prévenir les thromboses ?\nQuels conseils pour les patients à risque ?\nComment utiliser les bas de compression ?\nQuels aliments éviter pour prévenir les caillots ?\nComment gérer les facteurs de risque ?",
"url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Learning#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Antithrombiniques",
"description": "Quels médicaments sont des antithrombiniques ?\nComment administrer l'héparine ?\nQuels sont les effets secondaires des anticoagulants ?\nComment surveiller l'efficacité des anticoagulants ?\nQuels traitements pour la thrombose veineuse ?",
"url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Learning#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Antithrombiniques",
"description": "Quelles sont les complications des anticoagulants ?\nQuels risques d'une surdose d'anticoagulants ?\nComment gérer une hémorragie sous anticoagulants ?\nQuelles sont les complications de la thrombose ?\nQuels effets à long terme des anticoagulants ?",
"url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Learning#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Antithrombiniques",
"description": "Quels sont les facteurs de risque de thrombose ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue le tabagisme ?\nComment les maladies chroniques affectent-elles le risque ?\nQuel impact a la grossesse sur le risque ?",
"url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=Learning#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une thrombose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de thrombose se fait par échographie, D-dimères et examens cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'anticoagulation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le temps de prothrombine (TP) et l'INR pour surveiller l'anticoagulation."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une embolie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur thoracique, essoufflement et toux avec sang."
}
},
{
"@type": "Question",
"name": "Comment détecter une insuffisance veineuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuffisance veineuse se détecte par examen physique et Doppler veineux."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques d'une thrombose veineuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent œdème, rougeur, chaleur et douleur au niveau de la jambe."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une thrombose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement, rougeur et chaleur dans la zone affectée."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une embolie pulmonaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur thoracique aiguë, essoufflement et tachycardie."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une hémorragie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent saignements inhabituels, ecchymoses et fatigue excessive."
}
},
{
"@type": "Question",
"name": "Quels signes d'une thrombopénie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des saignements fréquents, des ecchymoses et des pétéchies."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une crise thromboembolique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une douleur soudaine, un essoufflement et une cyanose."
}
},
{
"@type": "Question",
"name": "Comment prévenir les thromboses ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'exercice régulier, l'hydratation et l'évitement de la sédentarité."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les patients à risque ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients à risque doivent suivre un traitement anticoagulant et éviter les voyages longs."
}
},
{
"@type": "Question",
"name": "Comment utiliser les bas de compression ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les bas de compression aident à améliorer la circulation et à réduire le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour prévenir les caillots ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments riches en vitamine K comme les légumes à feuilles vertes si sous anticoagulants."
}
},
{
"@type": "Question",
"name": "Comment gérer les facteurs de risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gérer les facteurs de risque inclut le contrôle du poids, l'arrêt du tabac et le traitement des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont des antithrombiniques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antithrombiniques incluent l'héparine, la warfarine et les nouveaux anticoagulants."
}
},
{
"@type": "Question",
"name": "Comment administrer l'héparine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'héparine est administrée par injection sous-cutanée ou intraveineuse selon les besoins."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des anticoagulants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent saignements, ecchymoses et réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'efficacité des anticoagulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se surveille par des tests sanguins réguliers comme l'INR et le temps de prothrombine."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la thrombose veineuse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent anticoagulants, compression et parfois intervention chirurgicale."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des anticoagulants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent hémorragies, thrombopénie et interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Quels risques d'une surdose d'anticoagulants ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surdose peut entraîner des saignements graves et nécessite une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Comment gérer une hémorragie sous anticoagulants ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas d'hémorragie, il faut arrêter l'anticoagulant et consulter un médecin rapidement."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la thrombose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, le syndrome post-thrombotique et la douleur chronique."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des anticoagulants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des saignements récurrents et des problèmes de coagulation."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de thrombose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, l'immobilité, les antécédents familiaux et certaines maladies."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de thrombose augmente avec l'âge en raison de la diminution de la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le tabagisme ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme augmente le risque de thrombose en favorisant l'inflammation et la coagulation."
}
},
{
"@type": "Question",
"name": "Comment les maladies chroniques affectent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies chroniques comme le diabète et l'hypertension augmentent le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Quel impact a la grossesse sur le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "La grossesse augmente le risque de thrombose en raison des changements hormonaux et circulatoires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/04/2025
Contenu vérifié selon les dernières recommandations médicales
9 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain.
8 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
5 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain. Electronic address: immlgi@um.es.
Publications dans "Antithrombiniques" :
4 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Publications dans "Antithrombiniques" :
4 publications dans cette catégorie
Affiliations :
Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Publications dans "Antithrombiniques" :
4 publications dans cette catégorie
Affiliations :
Hematology and Medical Oncology Unit, Morales Meseguer University Hospital, Regional Blood Donation Center, University of Murcia, Biomedical Research Institute of Murcia (IMIB), CIBER Rare Diseases (CIBERER), Murcia, Spain
Publications dans "Antithrombiniques" :
4 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Publications dans "Antithrombiniques" :
3 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain.
Publications dans "Antithrombiniques" :
3 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain.
Publications dans "Antithrombiniques" :
3 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain.
Publications dans "Antithrombiniques" :
3 publications dans cette catégorie
Affiliations :
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Publications dans "Antithrombiniques" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Publications dans "Antithrombiniques" :
3 publications dans cette catégorie
Affiliations :
Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Publications dans "Antithrombiniques" :
2 publications dans cette catégorie
Affiliations :
Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Publications dans "Antithrombiniques" :
IT tools has brought a new perspective to collaborative learning where students do not just sit in a chair and swallow lecture content but instead participate in creating and sharing knowledge. Howeve...
This research develops an interactive application for learning calculus that promotes human-system interaction via augmented reality (AR) and human-human interaction through chat functions. The study ...
The research adopted a quasi-experimental study design and pre-post test data analysis to evaluate the effect of interactivities on learning experience and consequently the effect of learning experien...
The results found that both interactivities affect learning experience positively; human-human interactivity has a higher impact than the human-system interactivity. It was also found that learning pe...
The application of non-cognitive factors represented by facial emotion in educational evaluation has attracted much attention in recent years. There are many existing studies on facial emotion assiste...
Binz et al. highlight the potential of meta-learning to greatly enhance the flexibility of AI algorithms, as well as to approximate human behavior more accurately than traditional learning methods. We...
Analysing movement learning can rely on human evaluation, e.g. annotating video recordings, or on computing means in applying metrics on behavioural data. However, it remains challenging to relate hum...
This study reports from a municipality in Norway that implemented a competence enhancement programme for all its institutional nursing staff during the COVID-19 pandemic to fill identified competence ...
Many Norwegian municipalities are experiencing a demand for expanded community healthcare services due to an increase in elderly patients and patients with extensive and complex needs. At the same tim...
Nursing staff were encouraged to complete targeted competence enhancing activities with the aim of enhancing their competence in identified areas. The learning activities were blended and consisted of...
The results provide insight into the competence development of registered nurses and assistant nurses in institutional community health services. They show that the implementation of a workplace-based...
Offering workplace-based competence enhancing activities seems to be a sustainable way of facilitating lifelong learning among nursing staff. Facilitation of learning activities in a blended learning ...
A spatial iterative learning control (sILC) method is proposed for a robot to learn a desired path in an unknown environment. When interacting with the environment, the robot initially starts with a p...
This study explores the interplay between Self-Determination (SDT), relatedness, and teaching presence and CoI's presence (teaching, cognitive, and social) in the context of online educational setting...
Our knowledge of the world is populated with categories such as dogs, cups, and chairs. Such categories shape how we perceive, remember, and reason about their members. Much of our exposure to the ent...
In contrast to conventional cognitive training paradigms, where learning effects are specific to trained parameters, playing action video games has been shown to produce broad enhancements in many cog...
Assessment can positively influence learning, however designing effective assessment-for-learning interventions has proved challenging. We implemented a mandatory assessment-for-learning system compri...
We conducted semi-structured interviews with year-3 and 4 medical students at McGill University to explore how the assessment system had influenced their learning in year 3. We conducted theory-inform...
Eleven students participated, revealing that the assessment influenced learning through several mechanisms. Some required little student engagement (i.e., feed-up, test-enhanced learning, looking thin...
Our assessment system failed to engage students enough to leverage its full potential. We discuss the inherent flaws and external factors that hindered student engagement. Assessment designers should ...